Oruka Therapeutics, Inc. Income Statement

Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2024
Revenue & cost
Revenue -0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M
Gross Profit -0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M
Operating items
Research & Development 3.11M2.31M1.09M2.93M5.62M7.06M12.35M14.08M4.24M1.83M4.99M13.83M4.75M
Selling, General & Administrative 6.07M5.05M3.23M4.01M4.07M4.39M4.26M4.64M3.88M3.98M4.77M5.50M5.85M
Operating Expenses 9.18M7.36M4.32M6.94M9.69M11.46M16.61M18.71M8.12M5.81M9.77M19.34M10.60M
Operating Income -9.18M-7.36M-4.32M-6.94M-9.69M-11.46M-16.61M-18.71M-8.12M-5.81M-9.77M-19.34M-10.60M
EBIT -9.18M-7.36M-4.32M-6.94M-9.69M-11.46M-16.61M-18.71M-8.12M-5.81M-9.77M-19.34M-10.60M
Non-operating items
Interest & Investment Income 0.76M0.00M0.00M0.01M0.01M0.01M0.17M0.17M0.16M0.17M0.03M0.01M0.68M
Net income details
EBT -8.42M-5.36M-4.32M-6.94M-9.69M-11.45M-16.44M-18.55M-7.96M-5.65M-9.75M-19.32M-9.93M
Tax Provisions -0.06M-0.03M-0.17M-0.01M
Profit After Tax -8.42M-5.36M-4.32M-6.94M-9.69M-11.45M-16.44M-18.49M-7.93M-5.48M-9.74M-19.32M-9.93M
Income from Continuing Operations -8.42M-5.36M-4.32M-6.94M-9.69M-11.45M-16.44M-18.49M-7.93M-5.48M-9.74M-19.32M-9.93M
Consolidated Net Income -8.42M-5.36M-4.32M-6.94M-9.69M-11.45M-16.44M-18.49M-7.93M-5.48M-9.74M-19.32M-9.93M
Income towards Parent Company -8.42M-5.36M-4.32M-6.94M-9.69M-11.45M-16.44M-18.49M-7.93M-5.48M-9.74M-19.32M-9.93M
Preferred Dividend Payments 2.03M
Net Income towards Common Stockholders -8.42M-5.36M-4.32M-8.96M-9.69M-11.45M-16.44M-18.49M-7.93M-5.48M-9.74M-19.32M-9.93M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M
Shares Outstanding (Weighted Average) 0.00M0.00M0.00M0.01M0.01M0.04M0.04M0.05M0.06M0.13M0.78M1.20M1.20M35.00M
EBITDA -9.18M-7.36M-4.32M-6.94M-9.69M-11.45M-16.46M-18.47M-7.93M-5.48M-9.77M-19.34M-10.60M
Tax Rate 0.33%0.39%2.96%0.09%